| | IGNITE Document | Needs Research | | | | | | | | | | | |
| | IGNITE Document | Needs Research | | | | | | | | | | | |
| | IGNITE Document | Needs Research | | | | | | | | | | | |
| | IGNITE Document | Needs Research | | | | | | | | | | | |
| | IGNITE Document | Needs Research | | | | | | | | | | | |
| | IGNITE Document | Needs Research | | | | | | | | | | | |
| | IGNITE Document | Needs Research | | | | | | | | | | | |
| | IGNITE Document | Needs Research | | | | | | | | | | | |
| | IGNITE Document | Needs Research | | | | | | | | | | | |
| | IGNITE Document | Needs Research | | | | | | | | | | | |
| | IGNITE Document | Needs Research | | | | | | | | | | | |
| | IGNITE Document | Needs Research | | | | | | | | | | | |
| | IGNITE Document | Needs Research | | | | | | | | | | | |
| | IGNITE Document | Not Needed | | | | | | | | | | | |
| | IGNITE Document | Needs Research | | | | | | | | | | | |
| | IGNITE Document | Not Needed | | | | | | | | | | | |
| | IGNITE Document | Needs Research | | | | | | | | | | | |
| | IGNITE Document | Needs Research | | | Template | | CYP2D6 – Opioids | | | | Academic Institutions | University of Florida Health Personalized medicine Program | |
| | IGNITE Document | Needs Research | | | Template | | CYP2D6 – Opioids | | | | Academic Institutions | University of Florida Health Personalized medicine Program | |
| | IGNITE Document | Needs Research | | | Template | | CYP2D6 – Opioids | | | | Academic Institutions | University of Florida Health Personalized medicine Program | |
| Done | IGNITE Document | Clinicians; Researchers | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Resources for Patients and Providers | Guidance document | resources for patients and providers | Research Tools | Patient Resources | | Algorithm for monogenic diabetes genetic testing MODY | Academic Institutions | University of Maryland | Implementation |
| Done | IGNITE Document | Clinicians | APOL1 | Clinical Decision Support | Image | Clinical Decision Support | APOL1 | Genetic testing | | APOL1 - Kidney Failure Best Practice Advisory (EPIC) | Academic Institutions | Mt. Sinai | Implementation |
| Done | IGNITE Link to Content | Clinicians | Resources for Patients and Providers | Resources for Patients and Providers | Website | resources for patients and providers | CYP2D6 – Opioids | Pharmacogenetics, Coding | | Applying for CPT Code | Other Organizations | AMA | Regulatory Issues |
| Done | IGNITE Document | Clinicians | CYP2C19 – Clopidogrel | Resources for Patients and Providers | Guidance document | Resources for Patients and Providers: CYP2C19- Clopidogrel | CYP2C19 – Clopidogrel | pharmacogenetics | | Article - UF PharmaNote - CYP2C19 and Clopidogrel | Academic Institutions | University of Florida | Implementation |
| Done | IGNITE Document | Clinicians | CYP2C19 – Clopidogrel | Resources for Providers | Guidance document | Resources for Patients and Providers: CYP2C19- Clopidogrel | CYP2C19 – Clopidogrel | pharmacogenetics | | Article - UF PharmaNote - CYP2C19 and Clopidogrel Clinical Outcomes | Academic Institutions | University of Florida | Implementation |
| Done | IGNITE Document | Clinicians | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Resources for Providers | Guidance document | Operational Elements | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Pharmacogenetics | | Article: UF PharmaNote - CYP2C19 and Clopidogrel | Academic Institutions | University of Florida | Implementation |
| Done | IGNITE Document | Clinicians | Additional Gene-Drug Pairs | Resources for Providers | Guidance document | Resource for Providers: Additional Gene-Drug Pairs | Additional Gene-Drug Pairs | pharmacogenetics | | Article: UF PharmaNote - CYP2C9 and VKORC1 for Warfarin | Academic Institutions | University of Florida | Implementation |
| Done | IGNITE Document | Clinicians | CYP2D6 and CYP2C19-SSRIs | Resources for Providers | Guidance document | Resources for Patients and Providers: CYP2C19- Clopidogrel | CYP2D6 and CYP2C19-SSRIs | pharmacogenetics | | Article: UF PharmaNote - CYP2D6 and CYP2C19 for SSRIs | Academic Institutions | University of Florida | Implementation |
| Done | IGNITE Document | Clinicians | CYP2D6 – Opioids | Resources for Providers | Guidance document | Resources for Patients and Providers: CYP2C19- Clopidogrel | CYP2D6 – Opioids | pharmacogenetics | | Article: UF PharmaNote - CYP2D6 and opioids | Academic Institutions | University of Florida | Implementation |
| Done | IGNITE Document | Clinicians | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Resources for Providers | Guidance document | Operational Elements | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Genomic medicine | | Article: UF PharmaNote - General Personalized Medicine Overview | Academic Institutions | University of Florida | Implementation |
| Done | IGNITE Document | Clinicians | Additional Gene-Drug Pairs | Operational Elements | Guidance document | Resource for Providers: Additional Gene-Drug Pairs | Additional Gene-Drug Pairs | pharmacogenetics | | Article: UF PharmaNote - HLA-B and Carbamazepine | Academic Institutions | University of Florida | Implementation |
| Done | IGNITE Document | Clinicians | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Policy and Best Practices | Guidance document | Operational Elements | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Pharmacogenetics | | Article: UF PharmaNote - Pharmacogeneticss Consult Clinic | Academic Institutions | University of Florida | Implementation |
| Done | IGNITE Link to Content | Clinicians | TPMT – Thiopurines | Implementation Site Surveys | Website | PharmGKB Resources: TPMT - Thiopurines | TPMT – Thiopurines | Provider resources | | Available guidelines for TPMT - Thiopurines | Other Organizations | PharmGKB | Implementation |
| Done | IGNITE Document | Researchers | Implementation Tools: Family History | | Form | Patient Surveys | Data Collection | Survey instruments | | Basic Patient demographics survey | Academic Institutions | University of Florida Health Personalized medicine Program | Data Standards & Interoperability |
| Done | IGNITE Document | Clinicians | Resources for Patients and Providers | Resources for Patients and Providers | Handout | Resources for patients and providers: CYP2D6 - Opioids | CYP2D6 – Opioids | Pharmacogenetics | | Breastfeeding and medication safety | Academic Institutions | MissionHealth | Implementation |
| Done | IGNITE Document | Clinicians | Family History | Operational Elements | Handout | Resources for Patients: Family History | Family History | Family Health History, Patient resources | | Brochure - Information on MeTree - a Tool for calculating genetic risks | Academic Institutions | IGNITE Network | Implementation |
| Done | IGNITE Document | Clinicians | Clinical Implementation of Genomic Medicine and Pharmacogenomics | PharmGKB Resources | Presentation | Operational Elements | Clinical Implementation of Genomic Medicine and Pharmacogenomics | pharmacogenetics | | Challenges Associated with Implementing Pharmacogenomics into Clinical Practice Presentation | Academic Institutions | Indiana University | Implementation |
| Done | IGNITE Link to Content | Clinicians | CYP2D6 and CYP2C19-SSRIs | Provider Surveys | Website | PharmGKB Resources: CYP2D6 and CYP2C19 SSRIs | CYP2D6 and CYP2C19-SSRIs | Pharmacogenetics | | Citalopram Pathway Diagram, Pharmacokinetics | Other Organizations | PharmGKB | Implementation |
| | IGNITE Document | Needs Research | Additional Gene-Drug Pairs | | Form | Student/Learner Surveys | Data Collection | Survey instruments, Pharmacogenetics | | Clinical applications in pharmacogenomics/genomic medicine post-course survey | Academic Institutions | University of Florida Health Personalized medicine Program | Data Standards & Interoperability |
| | IGNITE Document | Needs Research | Clinical Decision Support and Integration of Genetic Information into EHR | | Form | Student/Learner Surveys | Data Collection | Survey instruments, Pharmacogenetics | | Clinical applications in pharmacogenomics/genomic medicine pre-course survey | Academic Institutions | University of Florida Health Personalized medicine Program | Data Standards & Interoperability |
| | IGNITE Document | Needs Research | Additional Gene-Drug Pairs | Study Recruitment and Education Materials | Guidance document | Clinical Decision Support: Additional Gene-Drug pairs | Additional Gene-Drug Pairs | Pharmacogenetics | | Clinical Decision Support Alert Examples | Academic Institutions | Indiana University | Implementation |
| Done | IGNITE Document | Clinicians | TPMT – Thiopurines | Reimbursement and Coding for Genetic Testing | Guidance document | Evidence Overview: TPMT - Thiopurines | TPMT – Thiopurines | Pharmacogenetics | | clinical implementation publications | Academic Institutions | IGNITE Network | Implementation |
| Done | IGNITE Link to Content | Clinicians | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Resources for Patients and Providers | Website | reimbursement and coding for genetic testing | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Coding, reimbursement | | Clinical laboratory Fee schedule files | Government Institutions | centers for Medicare & Medicade services | Regulatory Issues |
| Done | IGNITE Document | Clinicians | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Resources for Patients and Providers | Guidance document | reimbursement and coding for genetic testing | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Coding, reimbursement | | Clinical Laboratory fee schedule for 2018 | Academic Institutions | centers for Medicare & Medicade services | Regulatory Issues |
| Done | IGNITE Link to Content | Clinicians | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Resources for Patients and Providers | Website | resources for patients and providers | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Provider Resources, Pharmacogenetics | | Clinical pharmacogenomcs implementation consortium | Other Organizations | CPIC | Implementation |
| Done | IGNITE Document | Clinicians | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Online Resources | Presentation | resources for patients and providers | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Pharmacogenetics | | Clinical Pharmacogenomics and the current medical paradigm presentation | Academic Institutions | Indiana University | Implementation |
| Done | IGNITE Link to Content | Clinicians | Mature Onset Diabetes of the Young (MODY) | Resources for Patients and Providers | Website | Resources for Patients and Providers: MODY | Mature Onset Diabetes of the Young (MODY) | Provider Resources, Diabetes | | Clinical Practice guideline for diagnosing and classifying diabetes | Other Organizations | American Diabetes Association | Implementation |
| Done | IGNITE Link to Content | Clinicians | CYP2C19 – Clopidogrel | Resources for Providers | Website | pharmGKB Resources: CYP2C19 - Clopidogrel | CYP2C19 – Clopidogrel | Pharmacogenetics | | Clopidogrel Pathways diagram | Other Organizations | PharmGKB | Implementation |
| Done | IGNITE Link to Content | Clinicians | CYP2D6 – Opioids | Policy and Best Practices | Website | PharmGKB Resources: CYP2D6 - Opioids | CYP2D6 – Opioids | Pharmacogenetics | | Codeine and Morphine Pathway diagram, Pharmacokinetics | Other Organizations | PharmGKB | Implementation |
| Done | IGNITE Link to Content | Clinicians | Family History | Online Resources | Website | Resources for Providers: Family history | Implementation Tools: Family History | Family Health History | | Collecting a family history | Other Organizations | AMA | Implementation |
| Done | IGNITE Document | Researchers | Research Tools | Clinical Decision Support | Form | Protocols | Research Tools | Family health history, cascade screening | | Coordinating center for implementing familial hypercholesterolemia cascade screening: a feasibility pilot | Academic Institutions | Duke Center for Applied Genomics and Precision Medicine | Implementation |
| | IGNITE Document | Needs Research | Genotyping Resources | Genotyping Resources | Handout | Resources for Patients and Providers: CYP2C19- Clopidogrel | CYP2C19 – Clopidogrel | Pharmacogenetics | | CPIC Guideline for CYP2C19 - Clopidogrel | Academic Institutions | University of Maryland SOM | Implementation |
| Done | IGNITE Link to Content | Clinicians | CYP2C19 – Clopidogrel | Clinical Pharmacogenetics Implementation Consortium Guideline Resources | Website | Clinical Pharmacogenetics Implementation Consortium | CYP2C19 – Clopidogrel | Pharmacogenetics | | CPIC Guideline for CYP2C19 - Clopidogrel | Other Organizations | CPIC | Implementation |
| Done | IGNITE Link to Content | Clinicians | CYP2D6 – Opioids | Clinical Pharmacogenetics Implementation Consortium Guideline Resources | Website | Clinical Pharmacogenetics Implementation Consortium Guideline Resouces: CYP2D6 - Opioids | CYP2D6 – Opioids | Pharmacogenetics | | CPIC Guideline for CYP2D6 - Codeine | Other Organizations | CPIC | Implementation |
| Done | IGNITE Document | Clinicians | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Clinical Pharmacogenetics Implementation Consortium Guideline Resources | Spreadsheet | reimbursement and coding for genetic testing | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Genetic testing, Coding | | CPT Code Spreadsheet | Academic Institutions | IGNITE Clinical Validity, Utility and Economics working group | Regulatory Issues |
| Done | IGNITE Document | Clinicians | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Resources for Providers | Guidance document | reimbursement and coding for genetic testing | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Coding, reimbursement | | CPT codes for Pharmacogenomic tests | Academic Institutions | IGNITE Network | Regulatory Issues |
| Done | IGNITE Document | Clinicians | CYP2C19 – Clopidogrel | Resources for Patients and Providers | Guidance document | Data Collection and implentation metrics: CYP2C19 | CYP2C19 – Clopidogrel | Pharmacogenetics | | CPY2C19 - Clopidogrel Data collection form for IGNITE outcomes collaboration | Academic Institutions | IGNITE Pharmacogenetics working group | Data Standards & Interoperability |
| Done | IGNITE Link to Content | Clinicians | Family History | Resources for Patients and Providers | Website | Resources for Providers: Family history | Implementation Tools: Family History | Family Health History | | Creating a family health history | Other Organizations | NIH National Library of Medicine: Medline Plus | Implementation |
| Done | IGNITE Link to Content | Clinicians | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Resources for Patients and Providers | Website | resources for patients and providers | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Provider resources, genetic variants | | CSER guide to interpreting genomic reports | Other Organizations | ASHG | Implementation |
| Done | IGNITE Document | Clinicians | CYP2C19 – Clopidogrel | Clinical Decision Support | Image | Clinical Decision Support: CYP2C19 - Clopidogrel | CYP2C19 – Clopidogrel | Pharmacogenetics | | CYP2C19 - Clopidogrel Best Practice Advisory Example (Epic) | Academic Institutions | Sanford | Implementation |
| Done | IGNITE Document | Clinicians | Resources for Patients and Providers | Resources for Patients and Providers | Image | Clinical Decision Support: CYP2C19 - Clopidogrel | CYP2C19 – Clopidogrel | Pharmacogenetics | | CYP2C19 - Clopidogrel clinical decision support language | Academic Institutions | Indiana University | Implementation |
| Done | IGNITE Document | Clinicians | CYP2C19 – Clopidogrel | Implementation Workflow Examples | Image | Clinical Decision Support: CYP2C19 - Clopidogrel | CYP2C19 – Clopidogrel | Pharmacogenetics | | CYP2C19 - Clopidogrel clinical decision support language | Academic Institutions | Indiana University | Implementation |
| Done | IGNITE Link to Content | Clinicians | CYP2C19 – Clopidogrel | Genotyping Resources | Website | PharmGKB Resources: CYP2C19 - Clopidogrel | CYP2C19 – Clopidogrel | Pharmacogenetics | | CYP2C19 - Clopidogrel Information page | Other Organizations | PharmGKB | Implementation |
| Done | IGNITE Link to Content | Clinicians | CYP2D6 and CYP2C19-SSRIs | Genotyping Resources | Website | PharmGKB Resources: CYP2D6 and CYP2C19 SSRIs | CYP2D6 and CYP2C19-SSRIs | Pharmacogenetics | | CYP2C19 - SSRIs Information page | Other Organizations | PharmGKB | Implementation |
| Done | IGNITE Document | Clinicians | CYP2C19 – Clopidogrel | Resources for Patients and Providers | Guidance document | genotyping Resources CYP2C19 - Clopidogrel | CYP2C19 – Clopidogrel | Pharmacogenetics | | CYP2C19 Genotype Translation table | Academic Institutions | Mt. Sinai | Implementation |
| Done | IGNITE Document | Clinicians | CYP2C19 – Clopidogrel | Resources for Providers | Guidance document | genotyping Resources CYP2C19 - Clopidogrel | CYP2D6 and CYP2C19-SSRIs | Pharmacogenetics | | CYP2C19 Genotype Translation table | Academic Institutions | University of Florida Health Personalized medicine Program | Implementation |
| Done | IGNITE Link to Content | Clinicians | CYP2C19 – Clopidogrel | Resources for Patients and Providers | Website | Resources for Patients and Providers: CYP2C19- Clopidogrel | CYP2C19 – Clopidogrel | Pharmacogenetics, Patient resources | | CYP2C19 Information page | Other Organizations | St. Jude's Children's Hospital | Implementation |
| Done | IGNITE Document | Clinicians | CYP2C19 – Clopidogrel | Online Resources | Presentation | Evidence Overview: CYP2C19 - Clopidogrel | CYP2C19 – Clopidogrel | Pharmacogenetics | | CYP2C19 Pharmacogenetic Competency Presentation | Other Organizations | St. Jude's Children's Hospital | Implementation |
| Done | IGNITE Document | Researchers | CYP2C19 – Clopidogrel | Resources for Patients and Providers | Handout | Study Recruitment and educational materials | | Human subjects regulations, Participant Resources, Pharmacogenetics | | CYP2C19 PPI study patient education sheet | Academic Institutions | University of Florida | Informed Consent & Human Subjects Protection |
| Done | IGNITE Document | Researchers | CYP2C19 – Clopidogrel | Research for Providers | Handout | Study Recruitment and educational materials | | Pharmacogenetics, Provider Resources | | CYP2C19 PPI study provider education sheet | Academic Institutions | University of Florida | Implementation |
| Done | IGNITE Document | Clinicians | CYP2C19 – Clopidogrel | Clinical Decision Support | Image | Clinical Decision Support: CYP2C19 - Clopidogrel | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Pharmacogenetics | | CYP2C19-Clopidogrel Best Practice Advisory Example (Epic) | Academic Institutions | University of Florida | Implementation |
| Done | IGNITE Document | Clinicians | CYP2C19 – Clopidogrel | Clinical Decision Support | Presentation | Clinical Decision Support: CYP2C19 - Clopidogrel | CYP2C19 – Clopidogrel | Provider resources | | CYP2C19-Clopidogrel Best Practice Advisory Examples and Flow Chart (Epic) | Academic Institutions | IGNITE Network | Implementation |
| Done | IGNITE Document | Clinicians | CYP2C19 – Clopidogrel | Resources for Patients and Providers | Image | Clinical Decision Support: CYP2C19 - Clopidogrel | CYP2C19 – Clopidogrel | Pharmacogenetics | | CYP2C19-Clopidogrel clinical decision support examples with drug-genome advisor | Academic Institutions | Vanderbilt University | Implementation |
| Done | IGNITE Document | Clinicians | CYP2C19 – Clopidogrel | Clinical Decision Support | Guidance document | Resource for Providers: Additional Gene-Drug Pairs | Additional Gene-Drug Pairs | pharmacogenetics | | CYP2C19-Proton-Pump-Inhibitor-Evidence-Summary | Academic Institutions | University of Florida | Implementation |
| Done | IGNITE Document | Clinicians | CYP2D6 – Opioids | Genotyping Resources | Image | Clinical Decision Support: CYP2D6 - Opioids | CYP2D6 – Opioids | Pharmacogenetics | | CYP2D6 - Codeine Best practices advisory (Epic0 | Academic Institutions | University of Florida Health Personalized medicine Program | Implementation |
| Done | IGNITE Document | Clinicians | CYP2D6 – Opioids | Resources for Patients and Providers | Guidance document | Clinical Decision Support: CYP2D6 - Opioids | CYP2D6 – Opioids | Pharmacogenetics | | CYP2D6 - Codeine Clinical decision support language | Academic Institutions | Indiana University | Implementation |
| Done | IGNITE Link to Content | Clinicians | CYP2D6 – Opioids | Resources for Providers | Website | PharmGKB Resources: CYP2D6 - Opioids | CYP2D6 – Opioids | Pharmacogenetics | | CYP2D6 - Codeine Information Page | Other Organizations | PharmGKB | Implementation |
| Done | IGNITE Document | Clinicians | CYP2D6 – Opioids | Resources for Patients and Providers | Guidance document | Resources for patients and providers: CYP2D6 - Opioids | CYP2D6 – Opioids | Pharmacogenetics | | CYP2D6 - Codeine Treatment recommendation flow chart | Academic Institutions | Indiana University | Implementation |
| Done | IGNITE Document | Clinicians | CYP2D6 – Opioids | Resources for Patients and Providers | Guidance document | Resources for patients and providers: CYP2D6 - Opioids | CYP2D6 – Opioids | Pharmacogenetics | | CYP2D6 - Codeine Treatment recommendation flow chart | Academic Institutions | Indiana University | Implementation |
| Done | IGNITE Link to Content | Clinicians | CYP2D6 and CYP2C19-SSRIs | Genotyping Resources | Website | PharmGKB Resources: CYP2D6 and CYP2C19 SSRIs | CYP2D6 and CYP2C19-SSRIs | Pharmacogenetics | | CYP2D6 - SSRI information page | Other Organizations | PharmGKB | Implementation |
| Questions | IGNITE Document | Clinicians | | | Guidance document | | CYP2D6 – Opioids | | | CYP2D6 and Opioid Conversion Information Sheet | Academic Institutions | University of Florida | |
| Done | IGNITE Document | Clinicians | CYP2D6 and CYP2C19-SSRIs | Study Recruitment and Education Materials | Spreadsheet | Genotyping Resources: CYP2D6 and CYP2C19 SSRIs | CYP2D6 – Opioids | Pharmacogenetics | | CYP2D6 genotype Translation table | Academic Institutions | University of Florida Health Personalized medicine Program | Implementation |
| Questions | IGNITE Document | Clinicians | | Resources for Patients and Providers | Spreadsheet | Genotyping Resources CYP2D6 - Opioids | CYP2D6 – Opioids | pharmacogenetics | | CYP2D6 Genotype Translation Tables for Codeine and Tramadol | Academic Institutions | Indiana University | Implementation |
| Questions | IGNITE Document | Clinicians | | | Template | | CYP2D6 – Opioids | | | CYP2D6 IM - Ortho Note Template | Academic Institutions | University of Florida Health Personalized medicine Program | |
| Done | IGNITE Link to Content | Clinicians | CYP2D6 – Opioids | Resources for Patients and Providers | Website | Resources for patients and providers: CYP2D6 - Opioids | CYP2D6 – Opioids | Pharmacogenetics | | CYP2D6 Information page | Other Organizations | St. Jude's Children's Hospital | Implementation |
| Questions | IGNITE Document | Clinicians | | | Template | | CYP2D6 – Opioids | | | CYP2D6 NM - Ortho Note Template | Academic Institutions | University of Florida Health Personalized medicine Program | |
| Questions | IGNITE Document | Clinicians | | | Template | | CYP2D6 – Opioids | | | CYP2D6 NM to UM - Ortho Note Template | Academic Institutions | University of Florida Health Personalized medicine Program | |
| | IGNITE Document | Needs Research | | | Handout | | | | | CYP2D6 Pain Medicine study patient education sheet (OneFlorida sites) | Academic Institutions | University of Florida | |
| Questions | IGNITE Document | Researchers | CYP2D6 – Opioids | | Handout | | CYP2D6 – Opioids | | | CYP2D6 Pain Medicine study patient education sheet (OneFlorida sites) | | | |
| Questions | IGNITE Document | Clinicians | | | Template | | CYP2D6 – Opioids | | | CYP2D6 PM - Ortho Note Template | Academic Institutions | University of Florida Health Personalized medicine Program | |
| Questions | IGNITE Document | Clinicians | | | Template | | CYP2D6 – Opioids | | | CYP2D6 UM - Ortho Note Template | Academic Institutions | University of Florida Health Personalized medicine Program | |
| Done | IGNITE Document | Clinicians | Clinical Implementation of Genomic Medicine and Pharmacogenomics | Online Resources: Research Tools | Guidance document | Operational Elements | Clinical Implementation of Genomic Medicine and Pharmacogenomics | pharmacogenetics | | Diagram of the gene-drug approval process in a health system | Academic Institutions | | Provider-Health Systems Interactions |
| Done | IGNITE Link to Content | Clinicians | PharmGKB Resources | PharmGKB Resources: CYP2D6 and CYP2C19-SSRIs | Website | resources for patients and providers | Clinical Implementation of Genomic Medicine and Pharmacogenomics | genetic testing | | DNAandU: stories of Use of genetic information in healthcare | Other Organizations | DNAandU | Implementation |
| Done | IGNITE Link to Content | Clinicians | CYP2D6 and CYP2C19-SSRIs | Resources for Patients and Providers | Website | Resources for patients and providers: CYP2D6 and CYP2C19-SSRIs | | Pharmacogenetics | | Drug-Gene Testing Information (Including CYP2D6 and CYP2C19-SSRIs) | Other Organizations | Mayo Clinic | Implementation |
| Done | IGNITE Document | Researchers | CYP2C19 – Clopidogrel | Resources for Patients and Providers | Presentation | study Recruitment and educational materials | | Family Health History | | Duke family health history pre-implementation presentation | Academic Institutions | Duke Center for Applied Genomics and Precision Medicine | Informed Consent & Human Subjects Protection |
| Done | IGNITE Document | Clinicians | CYP2C19 – Clopidogrel | Resources for Patients and Providers | Handout | Resources for Patients and Providers: CYP2C19- Clopidogrel | CYP2C19 – Clopidogrel | Pharmacogenetics, Patient resources | | Epic Template - Patient Education Letter for CYP2C19 Results | Academic Institutions | University of Maryland | Electronic Health Records |
| Done | IGNITE Document | Clinicians | CYP2C19 – Clopidogrel | Resources for Patients and Providers | Guidance document | Resources for Patients and Providers: CYP2C19- Clopidogrel | CYP2C19 – Clopidogrel | Pharmacogenetics, Provider Resources | | Epic Template - Provider Education Letter with Antiplatelet Treatment Recommendations | Academic Institutions | University of Maryland | Electronic Health Records |
| Done | IGNITE Document | Clinicians | CYP2C19 – Clopidogrel | Evidence Overview | Presentation | Evidence Overview: CYP2C19 - Clopidogrel | | Pharmacogenetics | | Evidence Overview of CYP2C19 - Clopidogrel Presentation | Academic Institutions | IGNITE Network | Implementation |
| Done | IGNITE Document | Clinicians | CYP2C19 – Clopidogrel | Evidence Overview | Presentation | Evidence Overview: CYP2C19 - Clopidogrel | CYP2C19 – Clopidogrel | Pharmacogenetics | | Evidence Overview of CYP2C19-Clopidogrel Presentation | Academic Institutions | IGNITE Network | Implementation |
| Done | IGNITE Document | Researchers | Family History | Research Tools | Template | Notifications for Study Participants | | Human subjects regulations, Test results, Genetic testing | | Example letter for disclosure of non-informative genetic test results | Academic Institutions | University of Maryland | Informed Consent & Human Subjects Protection |